ACT-09 RETROSPECTIVE INVESTIGATION ABOUT STATUS AND RESULT OF ADMINISTRATION OF BEVACIZUMAB FOR MALIGNANT GLIOMAS IN THE REAL WORLD

6 years have passed after approval of Bevacizumab for malignant gliomas in Japan, we analyzed the application and the results in our institution. Subjects were 56 patients who were histologically diagnosed as malignant gliomas. Bevacizumab was used in 41 patients among them. In 14 patients, Bevacizu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurooncol Adv
Autores principales: Hashiba, Tetsuo, Ueno, Katsuya, Naito, Nobuaki, Miyata, Mayuko, Yamamura, Natsumi, Lee, Ichi, Iwata, Ryoichi, Takeda, Junnichi, Yoshimura, Kunikazu, Nonaka, Masahiro, Asai, Akio
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213294/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.060
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares